Tissue factor pathway inhibitor (TFPI) is a critical anticoagulant protein present in endothelium and platelets. Mice lacking TFPI (Tfpi -/-) die in utero from disseminated intravascular coagulation. They are rescued by concomitant tissue factor (TF) deficiency, demonstrating that TFPI modulates TF function in vivo. Recent studies have found TFPI inhibits prothrombinase activity during the initiation of coagulation and limits platelet accumulation during thrombus formation, implicating TFPI in modulating platelet procoagulant activity. To examine whether altered platelet function would compensate for the lack of TFPI and rescue TFPI null embryonic lethality, Tfpi +/mice lacking the platelet thrombin receptor, PAR4 (Par4 -/-), or its co-receptor, PAR3, were mated. PAR3 deficiency did not rescue Tfpi -/embryos, but over 40% of expected Tfpi -/-:Par4 -/offspring survived to adulthood. Adult Tfpi -/-:Par4 -/mice did not exhibit overt thrombosis. However, they had focal sterile inflammation with fibrin(ogen) deposition in the liver and elevated plasma thrombin-antithrombin complexes, indicating activation of coagulation at baseline. Tfpi -/-:Par4 -/mice have platelet and fibrin accumulation similar to Par4 -/mice following venous electrolytic injury, but were more susceptible than Par4 -/mice to TF-induced pulmonary embolism. In addition, about 30% of the Tfpi -/-:Par4 -/mice were born with short tails. Tfpi -/-:Par4 -/mice are the first adult mice described that lack TFPI with unaltered TF.
Introduction
Tissue factor pathway inhibitor (TFPI) is a multivalent Kunitz-type protease inhibitor that exerts anticoagulant activity through inhibition of the blood coagulation proteases factor VIIa (fVIIa) and factor Xa (fXa). 1 By inhibiting these proteases, TFPI blocks the activity of two potent procoagulant enzyme complexes: 1) the tissue factor (TF)-fVIIa complex, 1,2 and 2) early forms of the prothrombinase complex consisting of fXa and partially B-domain cleaved forms of factor Va (fVa). 3 A human completely lacking TFPI has not been described, and TFPI knockout mice homozygous for the null allele (Tfpi tm1Gjb ; Tfpi -/-) die in utero, 4 highlighting the importance of TFPI anticoagulant activity during development. The embryonic lethal phenotype is rescued by concomitant deficiency of fVII 5 or markedly decreased expression of TF, 6 demonstrating that TFPI directly counterbalances TF-fVIIa activity during embryonic development. The ability of TFPIα to inhibit platelet prothrombinase activity during the initiation of coagulation is a more recently recognized anticoagulant function of TFPI. 3 It remains unknown if concomitant deficiency of platelet activation will rescue Tfpi -/mice from embryonic lethality.
Thrombin promotes blood coagulation through generation of fibrin and activation of platelets. It activates mouse platelets by cleaving protease activated receptors (PARs) 3 and 4 on the mouse platelet surface. 7 PAR3 contains a hirudin-like binding region (HLBR) that binds thrombin, but this does not result in downstream signaling through PAR3. Conversely, PAR4 can signal but does not contain a HLBR. Instead, PAR3 acts a co-receptor for PAR4 activation by localizing thrombin to the platelet membrane in the vicinity of PAR4. 8 Therefore, platelet activation through PAR4 in the absence of PAR3 requires higher thrombin concentration than For personal use only. on May 11, 2015 . by guest www.bloodjournal.org From when both receptors are present. 8 Thrombin-mediated activation of murine platelets does not occur in the absence of PAR4. 7 TFPI is produced predominantly by the endothelium. 9 However, it is also produced by megakaryocytes and is present within platelets. 10, 11 The importance of hematopoietic cell TFPI is demonstrated in a mouse model of hemophilia, where its absence improves the bleeding phenotype of these mice. 12 In addition, hematopoietic cell TFPI dampens thrombus volume following electrolytic vascular injury by limiting platelet accumulation without effect on fibrin accumulation. 13 This effect on platelet accumulation, but not fibrin accumulation, is similar to that observed when Par4 -/mice are subjected to vascular injury. 14 As platelet TFPI inhibits prothrombinase 3 and limits platelet accumulation at sites of vascular injury, 13 we hypothesized that a lack of platelet responsiveness to thrombin would compensate for the lack of TFPI and rescue the embryonic lethal phenotype associated with TFPI deficiency. To test this hypothesis, Par3 -/and Par4 -/mice were bred into Tfpi +/mice. Their F1 offspring were subsequently mated and examined for surviving Tfpi -/pups. Deficiency of PAR3 did not rescue the embryonic lethality of Tfpi -/embryos. In contrast, PAR4 deficiency rescued nearly half of Tfpi -/embryos to adulthood.
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Methods

Generation of mice
Mice heterozygous for the TFPI null allele (Tfpi tm1Gjb ;Tfpi +/-) were from Dr. George Broze, Jr.
(Washington University, St Louis). PAR3 and PAR4 deficient mice (F2rl2 -/-;Par3 -/and F2rl3-/-;Par4 -/-) were from Dr. Shaun Coughlin (University of California, San Francisco). All strains of mice were backcrossed on the C57Bl/6 background for at least 10 generations. Tfpi +/mice were mated with Par3 -/or Par4 -/mice to produce doubly heterozygous mice. Mice of the same PAR genotype were then mated to produce Tfpi +/-:Par3 -/and Tfpi +/-:Par4 -/mice. Tfpi +/mice of the same PAR genotype were then mated and the offspring genotyped to determine if lack of either PAR3 or PAR4 rescued the embryonic lethal phenotype of the TFPI null embryos. All experimental mice were male and 8-12 weeks old unless otherwise indicated.
Blood collection and sample preparation
Mice were anesthetized using ketamine/xylazine and blood collected via the inferior vena cava (IVC) into 3.2% citrate (9:1 ratio) using a 27G needle and syringe. For calibrated automated thrombography (CAT) assays, blood was drawn into 3.2% citrate (9:1 ratio) and corn trypsin inhibitor (50 µg/mL). Platelet poor plasma (PPP) was prepared by centrifugation of blood at 7,500 x g for 10 minutes at room temperature and the plasma collected then centrifuged at 20,000 x g for 10 minutes at 4°C.
Complete Blood Counts
Complete blood counts were determined using an animal blood counter (scil Vet abc Plus, Gurnee, IL).
Mouse tail length
At 8 weeks of age, the length of the tail, from the tail tip to the point at which the tail meets the body, was measured in millimeters. The mouse body length, from the nose to the point at which the tail meets the body, was also measured, and the ratio of the body length to tail length determined. The tail length was measured in mice with straight tails only. 
Quantitation of Thrombin-Antithrombin (TAT) Complexes and D-dimers
Histology
Mice were anesthetized with ketamine/xylazine and the major organs removed then fixed in 10% formalin. Tissues were paraffin-embedded and cut in 5 µm sections. The following antibodies were used for immunohistochemistry: anti-CD3 (AB828, Abcam, Cambridge, MA); anti-Fibrin(ogen) (A0080, Dako, Carpinteria, CA); anti-F4/80, and anti-Ly6B.2 alloantigen (MCA497G and MCA771G, both from AbD Serotec, Raleigh, NC). Biotinylated, speciesspecific secondary antibodies, and either streptavidin-horse radish peroxidase or streptavidinalkaline phosphatase and enzyme-specific substrates were used for detection. Slides stained with secondary antibody only served as a negative control. Liver lesion burden of Tfpi -/-:Par4 -/and Par4 -/mice (n=3, age <3 months for each genotype) was quantified using a calibrated reticle.
More than 15 fields per liver section were counted and averaged for each mouse to obtain the number of lesions per square mm.
Electrolytic Venous Injury Model
Electrolytic injury of the femoral vein was performed as previously described. 15 Briefly, the femoral vein was exposed in pentobarbital-anesthetized mice (50 mg/kg) and its surface injured by a 30-second electrolytic injury to a localized spot. Five minutes prior to the injury, rhodamine 6G (0.5 mg/kg, to label platelets in vivo) and AlexaFluor647-labeled anti-fibrin antibody were injected into mice via the external jugular vein in a 100 μ l volume. The anti-fibrin antibody was purified from ascites obtained from a hybridoma clone (59D8) kindly provided by Dr. Marschall 
Tissue Factor-Induced Pulmonary Embolism Model
Mice were weighed, anesthetized with ketamine/xylazine, and the IVC exposed. A 1/40 dilution of TF (diluted in PBS + 0.1% BSA; Hemoliance Recombiplastin, Instrumentation Laboratory, Bedford, MA) was injected via the IVC at a dose of 5 µL/g mouse, using a 27G needle attached to a 1 mL syringe. Mice were observed for signs of respiratory arrest over 30 minutes. The time of death, defined as the time to onset of respiratory arrest lasting two minutes, recorded. Mice surviving the 30 minute observation period were noted as survivors and sacrificed via cervical dislocation.
Statistics
Statistical analysis was performed using Graphpad Prism, version 4.0. Data were checked for normality using the D'Agostino & Pearson omnibus normality test before further statistical analysis. Mouse weight, plasma TAT complexes, and liver lesion burden were compared using the students' t-test. Data obtained in CAT assays was compared by one-way ANOVA with
Bonferroni's post test. For survival studies, Chi square analysis was performed using the log rank test. All data are presented as the mean ± standard deviation, unless otherwise stated. For all tests, p-value less than 0.05 were considered statistically significant. 
Results
Tfpi -/mice are rescued to wean by lack of PAR4, but not lack of PAR3
Tfpi +/mice lacking PAR3 or PAR4 were mated and the offspring genotyped at 21 days of age to determine if decreased platelet responsiveness to thrombin would rescue the embryonic lethal phenotype of TFPI null mice. Of 108 weanlings obtained from Tfpi +/-:Par3 -/x Tfpi +/-:Par3 -/matings, none were Tfpi -/-:Par3 -/-, demonstrating that concomitant lack of PAR3 in the mother and the fetus does not rescue the embryonic lethality of Tfpi -/mice (Table 1 ). In contrast, of 70 weanlings obtained from Tfpi +/-:Par4 -/x Tfpi +/-:Par4 -/matings, 8 (45.6% of expected)
were Tfpi -/-:Par4 -/-( Table 2 ). In addition to these 8 Tfpi -/-:Par4 -/weanlings, four Tfpi -/-:Par4 -/and two Tfpi +/-:Par4 -/pups were discovered dead or partially consumed. From the pattern of early perinatal survival (Figure 1 ), it can be inferred that at least 60% of the Tfpi -/-:Par4 -/mice survive embryogenesis. Of the adult Tfpi -/-:Par4 -/mice not sacrificed for experiments, 22 of 23 lived to over 8 months of age without overt signs of thrombosis.
Tfpi -/-:Par4 -/mice are fertile
Breeding studies were performed using Tfpi -/-:Par4 -/male (n = 2) or female (n = 4) mice mated to wild type or Tfpi +/-:Par4 -/mice. Tfpi -/-:Par4 -/mice of either gender successfully produced litters. In addition, a Tfpi -/-:Par4 -/breeding pair successfully produced two litters, though with reduced fecundity (7 pups in total while mated for approximately 6 months), demonstrating that TFPI is not absolutely required for reproduction. Most of the experimental mice used were from Tfpi -/-:Par4 -/males mated with Tfpi +/-:Par4 -/females, which produced 140
Tfpi -/-:Par4 -/mice from a total of 653 offspring (42.9% of the expected Mendelian frequency; Table 3 ).
For personal use only. on May 11, 2015. by guest www.bloodjournal.org From Tfpi -/-:Par4 -/mice are small and may have short and/or curly tails Tfpi -/-:Par4 -/mice weighed slightly less than their Tfpi +/-:Par4 -/littermates at eight weeks of age (21.8±2.5 g, n=32, vs 23.1±1.9 g, n=28; p<0.05). A more striking physical phenotype of the Tfpi -/-:Par4 -/mice was that approximately 30% were born with a short tail, typically varying from one-half to one-fourth the length of a normal tail ( Figure 2 ). The tail was completely absent in one mouse. All short tails were present at birth and did not shorten further over time. Some Tfpi -/-:Par4 -/mice also had curly or kinked tails (Figure 2A ). Tfpi -/-:Par4 -/mice with normal tail length maintained it for their lifetime.
Tfpi -/-:Par4 -/mice have sterile inflammatory lesions with associated fibrin deposition in the liver
Histological analysis was performed on the major organs from Tfpi -/-:Par4 -/mice, including the brain, heart, lungs, thymus, liver, spleen, and kidneys. Sterile infiltrates of inflammatory cells were present in all Tfpi -/-:Par4 -/mouse livers examined ( Figure 3 ). Two lesion types were observed. Smaller lesions, containing predominantly CD3+ lymphocytes and macrophages with fibrin(ogen) deposition, were most common ( Figure 3 , column 1). Rarely, larger, necrotic, fibrin(ogen)-rich lesions, containing neutrophils and surrounded by CD3+ lymphocytes, were also observed ( Figure 3 , column 2). Liver of Tfpi -/-:Par4 -/mice contained approximately 6-fold more lesions per mm 2 of tissue compared to Par4 -/mice (0.206 ± 0.031 vs 0.035 ± 0.039 lesions/mm 2 , respectively, p <0.005). Complete blood counts (CBCs) in [8] [9] [10] [11] [12] week old Tfpi -/-:Par4 -/mice were not different from CBCs in Par4 -/aged matched control mice (Table S1 ) indicating absence of a systemic inflammatory condition. The remaining organs were histologically normal when examined following trichrome staining. 1 3 Tfpi -/-:Par4 -/mice have elevated plasma TAT levels Plasma TAT complexes were increased approximately 2-fold in Tfpi -/-:Par4 -/mice compared to Par4 -/mice suggesting these mice have a systemic activation of coagulation when maintained under standard husbandry conditions ( Figure 4A ). Plasma TAT concentration was not different between young (8-12 weeks) and old (>8 months) mice of the same genotype (p>0.05). Plasma D-dimer was not detected in mice of any age or genotype.
The lack of plasma TFPI in Tfpi -/-:Par4 -/mice contributes to increased thrombin generation
Tissue factor-initiated CAT assays were performed using PPP from wild type, Par4 -/-, and Tfpi -/-:Par4 -/mice ( Figure 4B ). Thrombin generation profiles in wild type and Par4 -/-PPP were nearly identical, consistent with PAR4 having no effect on blood coagulation in plasma systems. The lack of functional TFPI in PPP obtained from Tfpi -/-:Par4 -/mice resulted in faster (p<0.01) and augmented (p<0.01) peak thrombin generation ( Figure 4 and Table S2 ).
TFPI deficiency does not affect in vivo thrombus formation in Par4 -/mice
To examine the effect of combined TFPI and PAR4 deletion on intravascular thrombus formation, electrolytic injury was used to trigger femoral vein thrombosis in wild type, Par4 -/-, and Tfpi -/-:Par4 -/mice. Consistent with a previous study that used a laser-induced cremaster arteriole injury model, 14 Par4 -/mice had decreased platelet accumulation but normal fibrin formation compared to wild type mice ( Figure 5 ). Tfpi -/-:Par4 -/mice also had decreased platelet accumulation and normal fibrin formation ( Figure 5 ) demonstrating that the absence of TFPI activity does not alter thrombus formation in mice lacking PAR4 in this model of vascular injury.
For personal use only. on May 11, 2015. by guest www.bloodjournal.org From Tfpi -/-:Par4 -/mice are more susceptible to tissue-factor induced pulmonary embolism than Par4 -/mice A pulmonary embolism model initiated by intravascular injection of TF was used to further examine the effect of combined TFPI and PAR4 deletion on intravascular thrombus formation. Eleven of 12 wild type mice succumbed to respiratory arrest within five minutes. In contrast, 12 of 12 Par4 -/survived the entire 30 minute observation period ( Figure 6 ), confirming previous studies demonstrating that the lack of PAR4 protects mice from TF-induced pulmonary embolism. 16 Two of six Tfpi -/-:Par4 -/mice succumbed to respiratory arrest within five minutes, while the remaining four survived the entire 30 minute observation period, demonstrating that the absence of TFPI activity partially over-rides the protective effect of PAR4 deficiency in this pulmonary embolism model. Tfpi -/mice die at two stages during embryonic development. 4, 6 On a C57Bl/6
background, approximately 30% die between E9.5 and E11.5 due to yolk sac hemorrhage and circulatory collapse, while the remaining 70% succumb to an apparent consumptive coagulopathy before birth. 4, 6 The rescue of this embryonic lethality by concomitant PAR4 deficiency, but not concomitant PAR3 deficiency, suggests that Tfpi -/embryos produce thrombin at a concentration sufficient to activate platelet PAR4 in the absence of PAR3, and that this platelet activation contributes to their demise. PAR4 is also expressed on endothelium; 17 For personal use only. on May 11, 2015. by guest www.bloodjournal.org From however, it is unlikely that this contributes to the embryonic rescue as bone marrow transplantation studies have found that the protection from thrombosis provided by PAR4 deficiency is accounted for entirely by the lack of thrombin activation of platelets. 18 In addition, thrombin signaling in mouse endothelial cells occurs primarily through PAR1. 17 This suggests that the lack of platelet PAR4 dampens development of the later stage consumptive coagulopathy, allowing birth of Tfpi -/embryos that survive the early stage yolk sac hemorrhage.
Male and female Tfpi -/-:Par4 -/mice are fertile. Male Tfpi +/-:Par4 -/and Tfpi -/-:Par4 -/mice produce Tfpi -/-:Par4 -/offspring at a similar Mendelian frequency when mated to Tfpi +/-:Par4 -/female mice, suggesting that the lack of TFPI in the male has little effect on reproductive efficiency. In contrast, fecundity is markedly reduced when Tfpi -/-:Par4 -/males are mated with Tfpi -/-:Par4 -/females. TFPI is produced by endothelial 19 and trophoblast 20 cells of the placenta, and placental TFPI prevents fibrin deposition and apoptosis that contributes to fetal death. 6 Findings presented here are consistent with those suggesting that maternal TFPI within the placenta is important for successful pregnancy outcome. 21 The most striking physical characteristic of Tfpi -/-:Par4 -/mice is the presence of short, curly, or kinked tails. This phenotype was also observed in the originally characterized Tfpi -/embryos, where they were associated with hemorrhage within the tail. 4 Deformed tails were not observed in Par4 -/mice, suggesting that they are caused by TFPI deficiency in the Tfpi -/-:Par4 -/mice. Of interest is that Tfpi -/-:TF low mice have normal tail length, 6 suggesting that the observed tail deformities may be caused by unfettered TF activity that is normally inhibited by TFPI.
Importantly, the Tfpi -/-:Par4 -/mice born with normal tails did not develop deformed tails over For personal use only. on May 11, 2015. by guest www.bloodjournal.org From their lifespan, as might be expected if they resulted from vascular thrombosis. Signaling through PAR1 and PAR2 contributes to neural tube closure and adult Par1 -/-:Par2 -/mice have curly tails. 22 TF indirectly signals through PAR1 by initiating thrombin production, and TFPIβ, an alternatively spliced form of TFPI on endothelium, 23 potently inhibits this activity. 24 TF-fVIIa can also signal through PAR2, either directly, or indirectly by promoting fXa production. 25 Thus, it is tempting to speculate that tail defects in the Tfpi -/-:Par4 -/mice develop as a consequence of altered TF-dependent PAR1 and/or PAR2 signaling. Alternatively, the tail defects could result from the action of thrombin on its other targets, such as GP1b or fibrinogen. Further studies are required to explore these possibilities.
Adult Tfpi -/-:Par4 -/mice do not display overt thrombosis. However, they exhibit augmented thrombin production in plasma CAT assays and elevated plasma TAT levels, implying the presence of systemic activation of coagulation. Thus, it appears that TFPI dampens intravascular prothrombotic stimuli that occur under standard husbandry conditions in Par4 -/mice. Since Par4 -/platelets are unresponsive to thrombin, this anticoagulant activity may be mediated by endothelial TFPI. A role for endothelial TFPI in dampening intravascular prothrombotic stimuli also is supported by the recent findings of elevated plasma D-dimer and prothrombin fragment 1+2 concentration in human subjects treated with intravenous or subcutaneous anti-TFPI antibody. 26 The presence of a prothrombotic condition in the Tfpi -/-:Par4 -/mice is further demonstrated by the presence of focal, mixed inflammatory cell infiltrates along with fibrin(ogen) deposition in the livers of Tfpi -/-:Par4 -/mice that develop under standard husbandry For personal use only. on May 11, 2015. by guest www.bloodjournal.org From conditions. It is notable that very similar lesions were observed in mice with combined TFPI heterozygosity and partial thrombomodulin deficiency (Tfpi +/-:Thbd pro/pro ), 21 and liver-specific fibrin deposition was noted in the original description of the Tfpi -/embryos. 4 Taken together, these data suggest that TFPI anticoagulant function is particularly important to regulate coagulation in the liver microenvironment, where the unique cellular composition and fenestrated endothelium demand strict control of hemostasis.
Par4 -/mice have decreased platelet accumulation but unaltered fibrin deposition in a cremaster arteriole laser-injury model, 14 suggesting that active coagulation complexes may form locally on cellular surfaces distinct from the platelet. Indeed, Ivanciu and co-workers recently demonstrated that prothrombinase can assemble on endothelium. 27 In a large-vessel venous electrolytic injury model, mice lacking hematopoietic cell TFPI produce thrombi with increased platelet accumulation but unaltered fibrin deposition. 13 Here, we used the same electrolytic injury model to find that Tfpi -/-:Par4 -/mice have decreased platelet accumulation and unaltered fibrin deposition at the injury site, mirroring the findings obtained in Par4 -/mice. Thus, the lack of PAR4 renders the anticoagulant activity of platelet TFPI unnecessary in this model. Tfpi -/-:Par4 -/mice also completely lack endothelial and plasma TFPI activity. Mice lacking endothelial TFPI have a shorter time to occlusion in a FeCl 3 -induced thrombosis model, 28 and the data presented here suggests that TFPI regulates TF-dependent, platelet-independent clot formation in a TFinduced pulmonary embolism model. Therefore, it was somewhat unexpected to find that fibrin generation was not different between wild type and Tfpi -/-:Par4 -/mice in the electrolytic injury model. It may be that TF exposure at the injury site overwhelms endothelial TFPI, effectively
For personal use only. on May 11, 2015. by guest www.bloodjournal.org From making this model insensitive to changes in endothelial TFPI, or that other anticoagulants, such as antithrombin and those in the Protein C/S system, compensate for the lack of TFPI.
To examine how the lack of TFPI alters TF-initiated coagulation in vivo, we utilized a pulmonary embolism model, in which clot formation is induced by the injection of TF directly into the vasculature. 16 Mice lacking PAR4 are completely protected from respiratory arrest in this model, suggesting that thrombin-dependent platelet activation is a primary cause of thrombus formation. The lack of TFPI in Tfpi -/-:Par4 -/mice partially reversed the protective effect of the lack of PAR4. This suggests that TF-dependent, platelet-independent clot formation (presumably fibrin-rich) may occur in this model, possibly on the surface of activated endothelium or the phospholipid in which the injected TF is embedded, and that this is inhibited by endothelial or plasma TFPI in Par4 -/mice.
The mechanisms whereby TFPI deficiency promotes consumptive coagulopathy and embryonic lethality in mice are not fully understood. Our studies here offer new insight into the cellular basis whereby TFPI inhibits this lethal procoagulant event. Specifically, the partial rescue of this embryonic death by concomitant lack of PAR4 strongly suggests that TFPI functions to dampen thrombin-mediated platelet activation and the ensuing consumptive coagulopathy during murine development. Tfpi -/-:Par4 -/mice surviving to adulthood have a prothrombotic phenotype associated with elevation in plasma TAT concentration and tissuespecific fibrin deposition in the liver, but without overt thrombosis. Collectively, the results suggest that the anticoagulant function of TFPI, mediated through either its ability to inhibit TF For personal use only. on May 11, 2015. by guest www.bloodjournal.org From 0 or its ability to inhibit early forms of prothrombinase, is essential for dampening of thrombinmediated platelet activation during embryogenesis and adult life. 
